Masakazu Haneda Selected Research

3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidine

1/2020	Long-Term Safety and Efficacy of Teneligliptin in Elderly Patients with Type 2 Diabetes: Subgroup Analysis of a 3-Year Post-Marketing Surveillance in Japan.
1/2020	Long-Term, Real-World Safety and Efficacy of Teneligliptin: A Post-Marketing Surveillance of More Than 10,000 Patients with Type 2 Diabetes in Japan.
6/2018	Relationship of Eating Patterns and Metabolic Parameters, and Teneligliptin Treatment: Interim Results from Post-marketing Surveillance in Japanese Type 2 Diabetes Patients.
6/2018	Safety and Efficacy of Teneligliptin in Patients with Type 2 Diabetes Mellitus and Impaired Renal Function: Interim Report from Post-marketing Surveillance.
2/2018	Safety and efficacy of long-term treatment with teneligliptin: Interim analysis of a post-marketing surveillance of more than 10,000 Japanese patients with type 2 diabetes mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masakazu Haneda Research Topics

Disease

49	Type 2 Diabetes Mellitus (MODY) 01/2021 - 03/2003
41	Diabetic Nephropathies (Diabetic Nephropathy) 02/2021 - 01/2002
20	Albuminuria 01/2021 - 03/2003
18	Hypertension (High Blood Pressure) 04/2016 - 02/2002
14	Proteinuria 12/2015 - 10/2004
12	Fibrosis (Cirrhosis) 11/2017 - 04/2003
10	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 09/2006
9	Body Weight (Weight, Body) 01/2020 - 06/2005
9	Hypoxia (Hypoxemia) 10/2018 - 05/2007
9	Hyperglycemia 10/2018 - 03/2003
8	Inflammation (Inflammations) 11/2018 - 06/2002
8	Hypoglycemia (Reactive Hypoglycemia) 01/2017 - 01/2011
8	Kidney Diseases (Kidney Disease) 01/2016 - 06/2005
7	Renal Insufficiency (Renal Failure) 02/2021 - 12/2004
6	Neoplasms (Cancer) 12/2021 - 01/2007
6	Diabetes Complications 01/2020 - 04/2009
6	Chronic Renal Insufficiency 10/2019 - 05/2003
4	Diabetes Mellitus 01/2020 - 10/2010
4	Obesity 04/2016 - 10/2010
4	Myocardial Infarction 03/2016 - 06/2012
4	Stroke (Strokes) 03/2016 - 06/2012
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2015 - 08/2006
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2012 - 08/2006
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 01/2009
2	Hypertrophy 10/2018 - 01/2005
2	Neoplasm Metastasis (Metastasis) 03/2018 - 01/2007
2	Glucose Intolerance 01/2017 - 10/2010
2	Insulin Resistance 01/2017 - 06/2006
2	Infections 06/2014 - 10/2010
2	Hemorrhage 05/2013 - 09/2012
2	Angina Pectoris 05/2013 - 06/2012
2	Alcoholic Fatty Liver 04/2013 - 01/2006
2	Non-alcoholic Fatty Liver Disease 04/2013 - 11/2004
2	Carcinoma (Carcinomatosis) 04/2013 - 01/2007
2	Wounds and Injuries (Trauma) 04/2011 - 03/2006
2	Edema (Dropsy) 01/2011 - 02/2005

Drug/Important Bio-Agent (IBA)

20	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 05/2003
19	AlbuminsIBA 02/2021 - 01/2005
16	CreatinineIBA 02/2021 - 03/2005
10	Proteins (Proteins, Gene)FDA Link 01/2016 - 02/2002
8	Nonesterified Fatty Acids (NEFA)IBA 01/2020 - 11/2010
7	Angiotensin Receptor AntagonistsIBA 01/2016 - 10/2004
6	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 11/2018 - 01/2015
6	Insulin (Novolin)FDA Link 06/2017 - 01/2009
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2003
5	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 01/2020 - 02/2018
5	LipidsIBA 10/2019 - 08/2003
5	empagliflozinIBA 10/2019 - 06/2014
5	SodiumIBA 04/2016 - 08/2006
5	Hypoglycemic Agents (Hypoglycemics)IBA 07/2015 - 01/2011
5	Messenger RNA (mRNA)IBA 04/2013 - 05/2007
4	LinagliptinIBA 01/2019 - 11/2015
4	Transcription Factors (Transcription Factor)IBA 01/2017 - 05/2007
4	olmesartanIBA 03/2016 - 09/2006
4	goralatideIBA 01/2016 - 04/2003
4	SaltsIBA 02/2012 - 07/2003
4	Antihypertensive Agents (Antihypertensives)IBA 08/2011 - 07/2003
4	Protein Kinase C betaIBA 04/2006 - 03/2003
3	Glucagon (Glukagon)FDA Link 01/2020 - 01/2017
3	PalmitatesIBA 12/2016 - 11/2010
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 04/2016 - 01/2014
3	Blood Glucose (Blood Sugar)IBA 04/2016 - 08/2009
3	Telmisartan (Micardis)FDA Link 04/2013 - 06/2007
3	Angiotensin IIIBA 02/2012 - 06/2006
3	CytokinesIBA 09/2011 - 01/2011
3	Collagen Type IV (Type IV Collagen)IBA 08/2010 - 01/2002
3	Transforming Growth Factor beta (TGF-beta)IBA 01/2007 - 03/2005
3	Fibronectins (Fibronectin)IBA 06/2005 - 02/2002
2	MicroRNAs (MicroRNA)IBA 12/2021 - 03/2018
2	IncretinsIBA 01/2020 - 01/2015
2	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2020 - 01/2015
2	KetonesIBA 01/2020 - 01/2016
2	Peptides (Polypeptides)IBA 01/2020 - 01/2016
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020 - 03/2018
2	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2018 - 04/2016
2	Hemoglobins (Hemoglobin)IBA 10/2018 - 02/2017
2	Mechanistic Target of Rapamycin Complex 1IBA 12/2016 - 07/2014
2	AMP-Activated Protein KinasesIBA 11/2016 - 03/2011
2	AngiotensinogenIBA 01/2016 - 06/2012
2	Pharmaceutical PreparationsIBA 01/2016 - 03/2011
2	Streptozocin (Streptozotocin)FDA Link 01/2016 - 02/2010
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2016 - 10/2004
2	Oxygen (Dioxygen)IBA 01/2014 - 03/2011
2	Metformin (Glucophage)FDA LinkGeneric 12/2011 - 03/2011
2	AntioxidantsIBA 09/2011 - 08/2003
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 09/2011 - 05/2003
2	Amlodipine (Norvasc)FDA LinkGeneric 08/2011 - 10/2006
2	Interleukin-18 (Interleukin 18)IBA 02/2011 - 02/2009
2	glimepiride (Amarel)FDA LinkGeneric 02/2011 - 09/2010
2	Sirtuin 1IBA 04/2010 - 01/2007

Therapy/Procedure

18	Therapeutics 01/2020 - 03/2003
4	Glycemic Control 06/2018 - 09/2005
3	Surgical Amputation (Amputations) 07/2022 - 03/2016
3	Renal Dialysis (Hemodialysis) 05/2013 - 06/2012
3	Kidney Transplantation 02/2010 - 07/2003
2	Exercise Therapy (Therapy, Exercise) 01/2017 - 12/2016
2	Drug Therapy (Chemotherapy) 01/2017 - 12/2016
2	Pancreaticoduodenectomy 01/2017 - 01/2007
2	Oral Administration 01/2016 - 12/2015
2	Aftercare (After-Treatment) 01/2011 - 04/2003